Vaping Was Supposed to Be Safe: The Emerging Evidence on E-Cigarettes and Lung Damage

Introduction: A Promise That May Not Hold

When e-cigarettes entered the consumer market in the mid-2000s, they arrived with an appealing narrative: a clean, modern alternative to the dirty, deadly combustible cigarette. No tar. No carbon monoxide. No ash. Just a sleek device delivering nicotine in a vapor that looked harmless and smelled like fruit, mint, or dessert. For millions of smokers desperate to quit, and for a generation of young people who had never touched a traditional cigarette, the promise was irresistible.

But the science of vaping has been catching up with the marketing, and the picture that is emerging is far more complicated — and far more concerning — than the industry has acknowledged. From the EVALI crisis that filled hospital wards in 2019 to mounting laboratory evidence of DNA damage, cardiovascular harm, and immune disruption, the emerging evidence makes clear that breathing aerosolized chemicals deep into the lungs multiple times per day is not the benign activity it was sold as.

This article examines what we now know about the health effects of e-cigarettes — the chemicals they contain, the damage they cause, the populations most at risk, and the critical distinction between less harmful than cigarettes and safe.

The EVALI Crisis: A Wake-Up Call

In the summer of 2019, hospitals across the United States began admitting patients — many of them young, otherwise healthy — with a mysterious and severe lung illness. Patients presented with cough, shortness of breath, chest pain, fever, and nausea. Chest imaging revealed bilateral ground-glass opacities: the lungs were filled with inflammatory fluid. Some patients required mechanical ventilation. Some died.

By February 2020, the CDC had identified 2,807 hospitalizations and 68 deaths from what was named EVALI — E-cigarette or Vaping Product Use-Associated Lung Injury.¹

Investigation ultimately linked the majority of EVALI cases to vitamin E acetate, an oily substance used as a thickening agent in illicit THC (marijuana) vaping cartridges. When inhaled, vitamin E acetate coats the lung lining and interferes with surfactant function, leading to a chemical pneumonitis.

However, several important caveats emerged:

• Approximately 14% of EVALI patients reported using only nicotine-containing products, not THC products, suggesting that other inhaled chemicals can also cause acute lung injury.
• The EVALI outbreak demonstrated a fundamental vulnerability of the vaping paradigm: the lungs are not designed to inhale aerosolized chemicals, and novel additives and contaminants can cause severe harm before regulators can identify and respond to the threat.
• The illicit market that produced vitamin E acetate cartridges exists in large part because of inadequate regulation of the vaping industry as a whole.

What's Actually in the Vapor?

E-cigarette liquid (commonly called e-liquid or vape juice) typically contains four categories of ingredients: a base liquid, nicotine, flavorings, and — after heating — a range of thermal degradation products and contaminants. Each category carries its own health concerns.

Propylene Glycol and Vegetable Glycerin

The base liquid is usually a mixture of propylene glycol (PG) and vegetable glycerin (VG). Both are FDA-approved as food additives for ingestion. However, safety for ingestion does not equal safety for inhalation. When heated to the temperatures used in e-cigarettes (200–300°C), PG and VG undergo thermal decomposition, producing toxic aldehydes including:

• Formaldehyde: A known Group 1 human carcinogen (IARC). E-cigarette vapor can contain formaldehyde at levels 5 to 15 times higher than in traditional cigarette smoke under certain operating conditions, particularly when the device is operated at high power settings or when the liquid runs low (a condition called a "dry puff").²
• Acrolein: A potent respiratory irritant and cardiovascular toxicant. Acrolein damages the airway epithelium and has been linked to the development of chronic obstructive pulmonary disease (COPD).
• Acetaldehyde: Another toxic aldehyde classified as a possible human carcinogen.

Heavy Metals from Heating Coils

The heating element (coil) in e-cigarettes is typically made of nichrome, stainless steel, or kanthal — alloys containing nickel, chromium, iron, and other metals. As the coil heats and degrades over time, metal particles leach into the aerosol and are inhaled directly into the lungs.

A study published in Environmental Health Perspectives found significant levels of lead, chromium, nickel, and manganese in e-cigarette aerosol. Lead was detected at levels exceeding EPA safe limits for air quality. Nickel and chromium are known carcinogens, and their presence in respirable aerosol is a serious concern.³

Flavoring Chemicals

The enormous variety of e-cigarette flavors — over 15,000 at last count — relies on hundreds of chemical flavoring compounds. Many of these are approved for use in food, but again, the critical distinction is that ingestion safety does not imply inhalation safety. The lungs and the digestive system process chemicals very differently.

The most notorious flavoring chemical is diacetyl, which produces a buttery taste and is associated with bronchiolitis obliterans, a severe and irreversible lung disease colloquially known as "popcorn lung" after it was identified in workers at a microwave popcorn factory who inhaled diacetyl vapors. Despite its known pulmonary toxicity, diacetyl has been detected in numerous e-cigarette products.⁴

Other flavoring chemicals of concern include 2,3-pentanedione (a diacetyl substitute with similar toxicity), cinnamaldehyde (used in cinnamon flavors, toxic to airway cells), and vanillin (which produces inflammatory responses in lung tissue at concentrations found in e-cigarette aerosol).

Nicotine: Not Just Addictive

Nicotine, the primary addictive substance in both traditional and electronic cigarettes, is often discussed solely in terms of addiction. But nicotine has direct cardiovascular and immunological effects that are clinically significant independent of addiction:

• Endothelial damage: Nicotine injures the endothelium — the single-cell-thick lining of blood vessels that is critical for vascular health. Endothelial damage is the initiating event in atherosclerosis.
• Blood pressure elevation: Nicotine activates the sympathetic nervous system, raising heart rate and blood pressure acutely with each use and chronically over time.
• Platelet activation: Nicotine promotes blood clotting by increasing platelet aggregation, raising the risk of thrombotic events like heart attack and stroke.
• Immune modulation: Nicotine alters both innate and adaptive immune function, suppressing some responses while enhancing others in ways that can increase susceptibility to infection and potentially impair tumor surveillance.⁵

Modern e-cigarettes, particularly pod-based devices, often deliver nicotine at concentrations comparable to or exceeding traditional cigarettes. Many popular products use nicotine salts, a formulation that allows very high nicotine concentrations (up to 50 mg/mL) to be inhaled smoothly, without the throat irritation that would normally limit intake.

Emerging Cancer Concerns

E-cigarettes have not existed long enough for epidemiological studies to determine whether they cause cancer in humans — such studies typically require 20–30 years of data. However, the laboratory evidence is deeply concerning.

A study published in Proceedings of the National Academy of Sciences exposed mice to e-cigarette aerosol equivalent to light vaping over 54 weeks. The results:

• 22.5% of the mice developed lung adenocarcinoma (a type of lung cancer), compared to none in the control group.
• 57.5% developed bladder urothelial hyperplasia, a pre-cancerous condition.
• The aerosol caused DNA damage in lung, bladder, and heart cells.⁶

Separately, in vitro studies have shown that e-cigarette aerosol extract causes DNA strand breaks, oxidative DNA damage, and reduced DNA repair capacity in human bronchial epithelial cells — the same type of cellular damage that precedes cancer development in smoking-related lung cancer.

The presence of known carcinogens in e-cigarette vapor — formaldehyde, acrolein, nitrosamines, and heavy metals — provides a mechanistic basis for cancer risk, even if the magnitude of that risk remains to be quantified.

Adolescent Brain Development

Perhaps the most alarming public health dimension of the vaping epidemic is its impact on adolescents. Nicotine is a potent neurotoxicant during brain development, which continues until approximately age 25. Adolescent exposure to nicotine can:

• Alter prefrontal cortex development: The prefrontal cortex, responsible for decision-making, impulse control, and attention, is particularly vulnerable to nicotine-induced changes during adolescence.
• Create stronger addiction: The adolescent brain is more susceptible to nicotine addiction than the adult brain. Young people who use nicotine become dependent faster and find it harder to quit.
• Prime the brain for other substance use: Animal studies have shown that adolescent nicotine exposure enhances the rewarding properties of other drugs, potentially serving as a gateway to broader substance use.
• Impair learning and memory: Nicotine alters hippocampal function during development, with potential long-term consequences for cognitive performance.⁷

Despite these risks, e-cigarette use among adolescents has reached epidemic proportions. The combination of appealing flavors, sleek device designs, social media marketing, and the misconception that vaping is harmless has created a generation of young nicotine addicts — many of whom never would have used tobacco products in the absence of e-cigarettes.

Industry Marketing to Youth

The e-cigarette industry's marketing practices have drawn intense scrutiny and regulatory action. Internal documents and advertising analyses have revealed strategies that parallel the historical playbook of the cigarette industry:

• Social media campaigns using young influencers and lifestyle imagery
• Flavors deliberately designed to appeal to young people (cotton candy, gummy bear, fruit punch, cereal milk)
• Sleek, discreet device designs that resemble USB drives and can be used without detection by parents or teachers
• Sponsorship of music festivals, sports events, and other youth-oriented venues
• Marketing claims of safety and harm reduction that create a perception of risk-free use

In 2020, the FDA banned the sale of flavored cartridge-based e-cigarettes (excluding tobacco and menthol flavors), but disposable flavored devices and open-system products remained available, effectively undermining the restriction.

Less Harmful Does Not Mean Safe

It is important to maintain scientific precision on this point: the best available evidence suggests that e-cigarettes are less harmful than combustible cigarettes for an individual smoker who switches completely from smoking to vaping. Combustible cigarettes remain the leading preventable cause of death worldwide, responsible for approximately 480,000 deaths annually in the United States alone. E-cigarettes eliminate the combustion-generated toxicants — tar, carbon monoxide, and thousands of chemicals produced by burning tobacco — that drive the majority of smoking-related mortality.

For adult smokers who have failed to quit through other means, switching to e-cigarettes may represent a harm reduction strategy, although the evidence for their effectiveness as cessation tools is mixed.

However, the relevant comparison for the majority of current vapers — particularly young people — is not vaping vs. smoking. It is vaping vs. not using any nicotine or inhaled product. In that comparison, vaping introduces substantial risk where none existed. It delivers addictive nicotine, toxic aldehydes, heavy metals, flavoring chemicals, and ultrafine particles into lungs that would otherwise be exposed to none of these substances.

Practical Recommendations

• If you don't vape, don't start. There is no health benefit to inhaling aerosolized chemicals.
• If you vape and have never smoked, understand that you are exposing yourself to documented health risks for no therapeutic benefit. Consider cessation resources including nicotine replacement therapy (patches, gum, lozenges) and behavioral support.
• If you switched from smoking to vaping, you have likely reduced your harm. The next step is to work toward complete cessation of nicotine products. Discuss evidence-based cessation strategies with your healthcare provider.
• If you are a parent, talk to your children about vaping early and factually. Scare tactics are less effective than honest conversations about addiction, the chemicals involved, and the evolving scientific evidence.
• Avoid illicit or unregulated products. The EVALI outbreak was driven by unregulated products. If you do use e-cigarettes, purchase only from licensed retailers and established manufacturers.
• Report symptoms promptly. If you experience persistent cough, shortness of breath, chest pain, or other respiratory symptoms, seek medical attention and inform your provider about your vaping history.

References

1. Blount, B. C., et al. "Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI." New England Journal of Medicine, vol. 382, no. 8, 2020, pp. 697–705.
2. Jensen, R. P., et al. "Hidden Formaldehyde in E-Cigarette Aerosols." New England Journal of Medicine, vol. 372, no. 4, 2015, pp. 392–394.
3. Olmedo, P., et al. "Metal Concentrations in E-Cigarette Liquid and Aerosol Samples: The Contribution of Metallic Coils." Environmental Health Perspectives, vol. 126, no. 2, 2018, 027010.
4. Allen, J. G., et al. "Flavoring Chemicals in E-Cigarettes: Diacetyl, 2,3-Pentanedione, and Acetoin in a Sample of 51 Products." Environmental Health Perspectives, vol. 124, no. 6, 2016, pp. 733–739.
5. Qiu, F., et al. "Impacts of Cigarette Smoking on Immune Responsiveness: Up and Down or Upside Down?" Oncotarget, vol. 8, no. 1, 2017, pp. 268–284.
6. Tang, M. S., et al. "Electronic-Cigarette Smoke Induces Lung Adenocarcinoma and Bladder Urothelial Hyperplasia in Mice." Proceedings of the National Academy of Sciences, vol. 116, no. 43, 2019, pp. 21727–21731.
7. Yuan, M., Cross, S. J., Bhatt, S. E., et al. "Nicotine and the Adolescent Brain." Journal of Physiology, vol. 593, no. 16, 2015, pp. 3397–3412.

Medical Disclaimer: This article is intended for informational and educational purposes only and does not constitute medical advice. The information presented reflects current scientific literature as of the date of publication and may be subject to revision as new research emerges. Always consult a qualified healthcare professional regarding tobacco or nicotine cessation or any health concerns.